Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma

ClinicalTrials.gov ID: NCT01025089

Public ClinicalTrials.gov record NCT01025089. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 10:24 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II Trial of Chemotherapy Plus Cetuximab Followed by Surgical Resection in Patients With Locally Advanced or Recurrent Thymoma or Thymic Carcinoma (BMS #CA225-331/Lilly Trial Alias I4E-US-X007)

Study identification

NCT ID: NCT01025089
Recruitment status: Active, not recruiting
Study type: Interventional
Phase: Phase 2
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Enrollment: 18 participants

Conditions and interventions

Conditions

Interventions

Cetuximab, Cisplatin, Doxorubicin & Cyclophosphamide Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Nov 30, 2009
Primary completion: Nov 30, 2026
Completion: Nov 30, 2026
Last update posted: Jan 6, 2026

2009 – 2026

United States locations

U.S. sites: 8
U.S. states: 4
U.S. cities: 8

Facility	City	State	ZIP	Site status
City of Hope Medical Center	Duarte	California	91010-3000	—
Memorial Sloan Kettering at Basking Ridge	Basking Ridge	New Jersey	07920	—
Memorial Sloan Kettering Cancer Center @ Suffolk	Commack	New York	11725	—
Memorial Sloan Kettering West Harrison	Harrison	New York	10604	—
Memorial Sloan Kettering Cancer Center	New York	New York	10065	—
Memorial Sloan Kettering at Mercy Medical Center	Rockville Centre	New York	—	—
Memorial Sloan Kettering Cancer Center at Phelps Memorial Hospital Center	Sleepy Hollow	New York	10591	—
Md Anderson Cancer Center	Houston	Texas	77030	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT01025089, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jan 6, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01025089 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →